Team

Meet the Management Team

  • Per Walday

    CEO

    30+ years’ experience developing pharmaceuticals from early preclinical to commercialisation. Previously CEO of PCI Biotech, managing development of drug-device combinations through FDA and EMA regulatory paths to late-stage development. Earlier positions include Global Head of Project Management GE Healthcare, with responsibility for all development programmes of new pharmaceuticals.

  • Svein Kvåle

    CO-FOUNDER AND COO

    25+ years’ experience from pharma R&D; Nycomed Imaging/Amersham Health/GE Healthcare, last ten as Sr. Scientist (GE). Inventor in 10+ patents within diagnostics and cancer therapeutics protecting 5 commercial products. Co-founder of EXACT Therapeutics AS.

  • Amir Snapir

    Amir Snapir

    CMO

    PhD from the University of Turku, Finland and MD from the University of Tel Aviv, Israel. Extensive experience in global clinical development of novel therapeutics, combined with extensive international regulatory experience. Dr Snapir also has years of experience in business collaborations, alliances and product co-developments. Earlier positions include CMO of PCI Biotech, where he was responsible for the clinical development of drug-device combination product candidates, and leader of clinical pharmacogenomics and clinical development leader in Oncology at Orion Pharma .

  • John M. Edminson

    CFO

    John has gained vast experience from various finance roles spanning over 20+ years, including being an auditor at KPMG Oslo, KPMG Boston, Telenor Mobile and Kistefos. Mr. Edminson also held the positions of CFO of PatientSky Group and Questback - both companies were listed on Euronext Growth during his time there.

  • Caspar Foghsgaard

    CBO

    Mr. Foghsgaard brings broad life science and commercial experience from listed and private companies. His latest roles have been with Nykode Therapeutics where he has served as Sr. Director Special Projects and been part of the extended leadership team. Prior to that, he was heading Nykode's business development activities as Director Business Development. He has also held business development and strategy roles at Arcus, Elopak and with Novozymes in Denmark, U.S. and U.K.

Meet the R&D Team

  • Ragnar Bendiksen

    VP OF TECHNOLOGY

    Graduate of NTNU within Electrical Engineering - Acoustics, Ragnar began his career at GE Healthcare in Oslo where he spent 14 years after which he joined Medistim ASA where he spent the next 10 years. Ragnar has always worked within Ultrasound and comes with a wealth of experience covering the different facets of ultrasound technology from bubbles to hardware, and from research to regulatory approval and commercialisation.

  • Morten Smedsrud Wigen

    ULTRASOUND DIRECTOR

    Morten completed his Master’s degree in 2013, on real-time display of streamed ultrasound and other physiological data sources. In 2019 he finished his PhD, on estimation and visualisation of blood flow imaging in 3D using ultrasound, from the Norwegian University of Science and Technology. He has over 8 years experience in the field of ultrasound from both academic research and from working in the industry with GE Vingmed Ultrasound.

  • Melina Mühlenpfordt

    PRECLINICAL DEVELOPMENT MANAGER

    Melina completed her Master’s degree in Molecular Life Sciences at the University Medical Center Hamburg Eppendorf in Germany where she worked within Infection Immunology. She is currently finishing her PhD in medical technology at NTNU working in close collaboration with EXACT Therapeutics on ACT® – Acoustic Cluster Therapy – for improved treatment of cancer and brain diseases. She has extensive experience in preclinical research having worked on translatable and innovative therapeutic concepts within oncology, neurology, immunology and infectious diseases from academia and industry including working for Novo Nordisk.

  • Ola Finneng Myhre

    ULTRASOUND DIRECTOR

    Ola has a Master’s degree in Electronics, Acoustics and Signal processing and a PhD in Medical Technology from the Norwegian University of Science and Technology (NTNU), where he worked with Prof. Bjørn Angelsen. He has several years of experience developing advanced ultrasound hardware, algorithms and software, both through his work at NTNU and as an engineer for GE Vingmed Ultrasound. He has a passion for technology development and joined EXACT Therapeutics after working as a development engineer at optical MEMS microphone company sensiBel AS.

  • Danishad Appu

    QA MANAGER AND CLINICAL ASSOCIATE

    Dani has a Masters Degree in Analytical Chemistry from Indian Institute of Technology Roorkee, India. He has several years of clinical research experience spanning investigator site, CRO, and study sponsor environments.

    He is a Registered Quality Assurance Professional in Good Clinical Practices (RQAP-GCP) through the Society of Quality Assurance (SQA) since 2017.

  • Lucy Wabakken

    VP REGULATORY AFFAIRS AND QA

    Lucy has more than 25 years of experience in pharma and biotech, including global regulatory management of a large product portfolio at Nycomed Pharma and Takeda, and regulatory and clinical development of drug-device combinations at PCI Biotech. Experienced in interactions with EMA, FDA and other regulatory authorities for marketing authorisation applications, scientific advice procedures, orphan designations, INDs and CTAs. She received her M. Sc. Pharm. degree from the University of Oslo.